ClinicalTrials.gg
Not yet recruitingNCT05442294PSIDUPUpdated Jul 1, 2022

"Juego de LLaves": Study Protocol of a Universal School-based Drug Use Prevention Program (PSIDUP)

An interventional study of Juego de Llaves in Behavior, Addictive, Adolescent - Emotional Problem and Alcohol Abuse, sponsored by Susana Al-Halabí. Not yet recruiting at 1 site in Spain. Open to participants aged 12 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-01.

Primary conditionBehavior, Addictive(the registry's first term)UnverifiedIs this wrong?Behavior, Addictive is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Susana Al-Halabí · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2023, 3 years 4 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2,500
Allocation
Non-randomized
Ages
12 Years to 15 Years
Sex
All
01

Study summary

"Juego de Llaves" is a universal school-based drug prevention program for adolescents aged 12-15 years. The outcome evaluation is critical to determine the quality of preventive interventions. This protocol describes the full protocol of the evaluation design, instruments, randomization procedure, follow-ups, and primary outcomes. Method: Non-Randomized Control Cluster Trial in a set of Spanish school centers at the compulsory secondary education level, with follow-ups at 12-, 24- and 36-months. Participants will be allocated to an experimental or control (no intervention) group. Using an electronic ad-hoc designed App, a battery of instruments will be used to assess addictive behaviors, sociodemographic variables, school climate and other transdiagnostic psychological variables. A piloting test will be conducted to test the implementation protocol and to calculate the sample size needed for the outcome evaluation. After implementing the program, longitudinal statistical approaches will be used to inform on the intervention efficacy and potential moderators and mediators. There is a lack of effectiveness assessments of school prevention programs, and it is expected that this protocol will expedite the monitoring and ongoing evaluation in prevention.

02

Conditions studied

  • Behavior, Addictive
  • Adolescent - Emotional Problem
  • Alcohol Abuse
  • Smoking Behaviors
  • Adolescent Behavior
  • Psychological

Browse trials for

Keywords

  • Adolescents
  • Addictive behaviors
  • Evaluation
  • Universal school-based prevention
  • Transdiagnostic approach
03

In context

Behavior, Addictive Unverified

522 studies on the registry are indexed under Behavior, Addictive; 125 are open to participants now.

This study's planned enrollment of 2,500 is above the median of 62 across 399 interventional studies indexed under Behavior, Addictive.

Browse Behavior, Addictive studies →

Lead sponsor

This is the only study on the registry with Susana Al-Halabí as lead sponsor.

Compared within Behavior, Addictive, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
12 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Schools having secondary education.
  • Schools located in Spain.
  • Schools willing to participate under the conditions of the study before randomization.

Exclusion criteria

Exclusion Criteria:

  • Schools having other interventions with a strong package on substance use prevention targeted the same grades.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
2,500 participants (estimated)

Study arms

  • Experimental
    Juego de Llaves group

    This group will receive the prevention program during the academic year in school hours. The prevention program is called Juego de Llaves. The main goal of this program is to prevent substance use and engagement in other addictive behaviors. It is intended to be delivered by teachers in a six to twelve session format through different modules that cover the following areas: emotional regulation, cognitive strategies, social interaction, free time, education on drugs and life values

    Behavioral: Juego de Llaves

  • No intervention
    Control group

    The control group will receive the usual teaching activities regarding substance use prevention.

Interventions

  • BehavioralJuego de Llaves

    The main goal of this program is to prevent substance use and engagement in other addictive behaviors. It is intended to be delivered by teachers in a six to twelve session format through different modules that cover the following areas: emotional regulation, cognitive strategies, social interaction, free time, education on drugs and life values

06

What researchers measure

Primary outcomes

  1. Substance use: Tobacco

    Ítems from the survey on drug use in secondary education in Spain (ESTUDES) for the National Plan on Drugs

    Time frame: Past 30-day period

  2. Substance use: Alcohol

    Ítems from the survey on drug use in secondary education in Spain (ESTUDES) for the National Plan on Drugs

    Time frame: Past 30-day period

  3. Substance use: Cannabis

    Ítems from the survey on drug use in secondary education in Spain (ESTUDES) for the National Plan on Drugs

    Time frame: Past 30-day period

  4. Non-substance use behavior: Gaming

    Ítems from the survey on drug use in secondary education in Spain (ESTUDES) for the National Plan on Drugs

    Time frame: Past 30-day period

  5. Non-substance use behavior: Gambling

    Ítems from the survey on drug use in secondary education in Spain (ESTUDES) for the National Plan on Drugs

    Time frame: Past 30-day period

  6. Reinforcement ratio

    Ad-hoc questionnaire (SAUPI; unpublished)

    Time frame: Past-year period

  7. Consecuences of addictive behaviors

    ARSS-SUV (adapted from Murphy et al., 2005)

    Time frame: Past 30-day period

Secondary outcomes

  1. Resilience

    The Child and Youth Resilience Measure, CYMR (Resilience Research Centre, 2018)

    Time frame: Past 30-day period

  2. Behavioral problemas

    Strengths and Difficulties Questionnaire (25-item version), SDQ (Ortuño-Sierra et al., 2018)

    Time frame: Past 30-day period

  3. Emotion regulation

    The Emotional Regulation Questionnaire - adolescents, ERQ-CA (Navarro et al., 2018)

    Time frame: Past 30-day period

  4. Suicidal behavior

    The Paykel Suicide Scale, PSS (Fonseca-Pedrero et al., 2018)

    Time frame: Past 30-day period

  5. Impulsivity

    The Scale of Impulsivity for Children and Adolescents BUPPS-P-NA (Caneto et al., 2020)

    Time frame: Past 30-day period

07

Study locations

1 site
  • Grupo de Conductas Adictivas, University of Oviedo
    Oviedo, Asturias 33006, Spain
08

References and documents

Related links

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2022; primary completion for Jun 2023, 9 months later.

Of 148 non-industry interventional studies with no phase under Behavior, Addictive, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 42. This study's planned 9 months is below that.

Counting every sponsor, half of 156 studies reached it within 26 months; a quarter within 10 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 15, 2022
First posted
Jul 1, 2022
StartEst.
Sep 1, 2022
Primary completionEst.
Jun 30, 2023
CompletionEst.
Dec 30, 2025
Last update
Jul 1, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 1, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05442294
Lead sponsor
Susana Al-Halabí
Collaborators
United Nations Office on Drugs and Crime (UNODC), Asociación Proyecto Hombre
Responsible party
Susana Al-Halabí (Associate Professor at the Department of Psychology, University of Oviedo) — Sponsor-investigator
First posted
Jul 1, 2022
Start date
Sep 1, 2022 (estimated)
Primary completion
Jun 30, 2023 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
Jul 1, 2022

Study contacts

Susana Al-Halabí, PhD
Contact
alsusana@uniovi.es
+34 985104199

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion